Cargando…
Corrigendum to: Development of bispecific antibodies in China: overview and prospects
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972275/ https://www.ncbi.nlm.nih.gov/pubmed/35372785 http://dx.doi.org/10.1093/abt/tbab029 |
| _version_ | 1784679803845083136 |
|---|---|
| author | Zhang, Jing Yi, Jizu Zhou, Pengfei |
| author_facet | Zhang, Jing Yi, Jizu Zhou, Pengfei |
| author_sort | Zhang, Jing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8972275 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89722752022-04-01 Corrigendum to: Development of bispecific antibodies in China: overview and prospects Zhang, Jing Yi, Jizu Zhou, Pengfei Antib Ther Corrigendum Oxford University Press 2022-01-19 /pmc/articles/PMC8972275/ /pubmed/35372785 http://dx.doi.org/10.1093/abt/tbab029 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Corrigendum Zhang, Jing Yi, Jizu Zhou, Pengfei Corrigendum to: Development of bispecific antibodies in China: overview and prospects |
| title | Corrigendum to: Development of bispecific antibodies in China: overview and prospects |
| title_full | Corrigendum to: Development of bispecific antibodies in China: overview and prospects |
| title_fullStr | Corrigendum to: Development of bispecific antibodies in China: overview and prospects |
| title_full_unstemmed | Corrigendum to: Development of bispecific antibodies in China: overview and prospects |
| title_short | Corrigendum to: Development of bispecific antibodies in China: overview and prospects |
| title_sort | corrigendum to: development of bispecific antibodies in china: overview and prospects |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972275/ https://www.ncbi.nlm.nih.gov/pubmed/35372785 http://dx.doi.org/10.1093/abt/tbab029 |
| work_keys_str_mv | AT zhangjing corrigendumtodevelopmentofbispecificantibodiesinchinaoverviewandprospects AT yijizu corrigendumtodevelopmentofbispecificantibodiesinchinaoverviewandprospects AT zhoupengfei corrigendumtodevelopmentofbispecificantibodiesinchinaoverviewandprospects |